lolloj / Shutterstock.com
More than 15,000 life sciences industry professionals will arrive in San Diego this month for the annual BIO International Convention. LSIPR looks at some of the most interesting sessions, and talks to a couple of speakers.
This year’s annual Biotechnology Industry Organization (BIO) International Convention couldn’t start at a better time.
Mere weeks after a rash of big decisions from the US Supreme Court, there will be plenty to discuss at the conference’s IP sessions—not just the ruling on Roslin, which found that mammals made using the cloning method that produced Dolly the sheep are not patentable, but also Nautilus and Limelight which, while concerning tech patents, could also have an impact on the life sciences industry.
More than 15,000 industry professionals are expected to attend the conference, which this year sets up at the heart of the US’s second life sciences cluster, at San Diego’s Convention Center from June 23 to 26.
You need a subscription to continue reading this content.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
BIO, US Supreme Court, WIPO,